Christopher J. Kirk Kezar Life Sciences, Inc. (KZR) insider trading activity
Christopher J. Kirk is CEO of Kezar Life Sciences, Inc.. Currently has a direct ownership of 431,348 shares of KZR, which is worth approximately $3.22 Million. The most recent transaction as insider was on Jul 20, 2023, when has been sold 48,950 shares (Common Stock) at a price of $0.9 per share, resulting in proceeds of $44,055. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
431K
0%
3M change
0%
12M change
Total Value Held
$3.22 Million
Christopher J. Kirk Transaction History
CJK
Christopher J. Kirk
CEO
South San Francisco, CA